Repositori Obert UdL
Publicación
Artículo científico (JournalArticle)
Industrial By-Products As a Novel Circular Source of Biocompatible Extracellular Vesicles
Extracellular vesicles (EVs) constitute an intricate system of molecular
exchange that has recently gained tremendous interest. However, sustainable
sources of safe biological EVs remain scarce and elusive. This study explores
and defines the use of food industry by-products (BP) as a circular source
of safe biocompatible EVs. Averaged diameter and molecular compositions
indicate a large yield of exosomes and high abundancy of membrane lipids with
signaling capacity in these vesicles. Complex proteomes mimicking those
circulating in human blood plasma are also identified. Furthermore, BP-EVs
do not show relevant cytotoxicity and display excellent oral and intravenous
bioavailability together with specific organ targeting capacity. Collectively, it is
believed that the novel findings reported here will open substantial venues for
the use of BP as an optimal source of biocompatible nanovesicles in manifold
applications of the biotechnological and biomedical fields., The authors sincerely thank Gemma Plaza, oenologist at the Castell del Remei winery in Penelles, Lleida, Spain and Juan Carlos Blanco, production manager at Mahou San Miguel in Alovera, Madrid, Spain for their kind and altruistic help on the obtention of their respective industry by-product samples. The authors also thank Dr. Hector Peinado and his research group at the National Center for Oncology Research (CNIO) in Madrid (Spain) for their support on the morphometric characterization of BP-EVs. Support for this work was provided by the Research and Education Council of the Community of Madrid, Spain (2018-T1/ BIO-10633), Ministry of Science and Innovation, Spain (PID2020- 114885RB-C21) and a FIS project by Carlos III Institute of Health (ISCIII), Spain (PI20/00623). A.S. acknowledges a grant from the Talento Program 2018 of the Community of Madrid. X.G.-P. acknowledges grants from Sara Borrell postdoctoral program (CD19/00243) and Miguel Servet tenure track program (CP21/00096) of the Instituto de Salud Carlos III (ISCIII, Spain), respectively awarded on the 2019 and 2021 calls under ISCIII-Health Strategy Actions [These grants are cofunded with European Union Funds (ISCIII Miguel Servet Program 2021 is cofunded by Fondo Social Europeo Plus, FSE+)]. M.V.C. acknowledges a Miguel Servet program contract (CPII20/00007). C.L.’s Ph.D. was funded by the Regional Ministry of Science, Universities and Innovation of the Community of Madrid and the European Social Fund for the recruitment of predoctoral researchers (PEJD-2019-PRE/BIO-16475). IRBLLEIDA and X.G.-P. are co-funded by CERCA Program/Generalitat de Catalunya.